Terms: = Breast cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394 AND Treatment
18 results:
1. Suppression of AGRN enhances CD8+ T cell recruitment and inhibits breast cancer progression.
Tao J; Shen L; Zhuang M; Zhai C; Zeng H; Mao Y; Liu X
FASEB J; 2024 Apr; 38(7):e23582. PubMed ID: 38568853
[TBL] [Abstract] [Full Text] [Related]
2. A Review on the Role of Exercise Training to Prevent a Decline in Cardiorespiratory Fitness and Cardiac Function in breast cancer Survivors.
Foulkes SJ; Howden EJ; Pituskin E; Thompson RB; La Gerche A; Haykowsky MJ
J Cardiopulm Rehabil Prev; 2024 Jan; 44(1):5-14. PubMed ID: 38032257
[TBL] [Abstract] [Full Text] [Related]
3. Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive breast cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.
Ding Y; Mo W; Xie X; Wang O; He X; Zhao S; Gu X; Liang C; Qin C; Ding K; Yang H; Ding X
Oncol Res Treat; 2023; 46(7-8):303-311. PubMed ID: 37302393
[TBL] [Abstract] [Full Text] [Related]
4. The dosimetric benefit of in-advance respiratory training for deep inspiration breath holding is realized during daily treatment in left breast radiotherapy: A comparative retrospective study of serial surface motion tracking.
Kalet AM; Kim A; Hippe DS; Lo SS; Fang LC; Meyer J; Lang EV; Mayr NA
J Med Imaging Radiat Oncol; 2021 Jun; 65(3):354-364. PubMed ID: 33932102
[TBL] [Abstract] [Full Text] [Related]
5. Intracystic breast carcinoma. An important differential diagnosis in postmenopausal patients presenting with a rapidly growing breast cyst. Management and literature review.
Salemis NS
Breast Dis; 2018; 37(4):219-224. PubMed ID: 29562482
[TBL] [Abstract] [Full Text] [Related]
6. Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET).
Jerusalem G; Mariani G; Ciruelos EM; Martin M; Tjan-Heijnen VC; Neven P; Gavila JG; Michelotti A; Montemurro F; Generali D; Simoncini E; Lang I; Mardiak J; Naume B; Camozzi M; Lorizzo K; Bianchetti S; Conte P
Ann Oncol; 2016 Sep; 27(9):1719-25. PubMed ID: 27358383
[TBL] [Abstract] [Full Text] [Related]
7. Heparan sulfate proteoglycans and human breast cancer epithelial cell tumorigenicity.
Okolicsanyi RK; van Wijnen AJ; Cool SM; Stein GS; Griffiths LR; Haupt LM
J Cell Biochem; 2014 May; 115(5):967-76. PubMed ID: 24357546
[TBL] [Abstract] [Full Text] [Related]
8. A new paradigm for calculating skin dose.
Gifford KA; Pacha O; Hebert AA; Nelson CL; Kirsner SM; Ballo MT; Bloom ES
Brachytherapy; 2013; 12(2):114-9. PubMed ID: 22884255
[TBL] [Abstract] [Full Text] [Related]
9. [Combination of recombinant human endostatin and neoadjuvant chemotherapy for breast cancer].
Chen JH; Li D; Yao Q; Zhang JL; Wang T; Wang L
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(10):668-71. PubMed ID: 22781292
[TBL] [Abstract] [Full Text] [Related]
10. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex.
Xu J; Zhang Y; Berry PA; Jiang J; Lobie PE; Langenheim JF; Chen WY; Frank SJ
Mol Endocrinol; 2011 Apr; 25(4):597-610. PubMed ID: 21310852
[TBL] [Abstract] [Full Text] [Related]
11. The calcium sensing receptor: from understanding parathyroid calcium homeostasis to bone metastases.
Mihai R
Ann R Coll Surg Engl; 2008 May; 90(4):271-7. PubMed ID: 18492387
[TBL] [Abstract] [Full Text] [Related]
12. Hypoxia and estrogen co-operate to regulate gene expression in T-47D human breast cancer cells.
Seifeddine R; Dreiem A; Tomkiewicz C; Fulchignoni-Lataud MC; Brito I; Danan JL; Favaudon V; Barouki R; Massaad-Massade L
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):169-79. PubMed ID: 17475478
[TBL] [Abstract] [Full Text] [Related]
13. Long-term survival in node-positive breast cancer treated by locoregional therapy alone.
Joensuu H; Pylkkänen L; Toikkanen S
Br J Cancer; 1998 Sep; 78(6):795-9. PubMed ID: 9743303
[TBL] [Abstract] [Full Text] [Related]
14. Two-dimensional models of tumour angiogenesis and anti-angiogenesis strategies.
Orme ME; Chaplain MA
IMA J Math Appl Med Biol; 1997 Sep; 14(3):189-205. PubMed ID: 9306674
[TBL] [Abstract] [Full Text] [Related]
15. A controlled trial of extended radical versus radical mastectomy. Ten-year results.
Meier P; Ferguson DJ; Karrison T
Cancer; 1989 Jan; 63(1):188-95. PubMed ID: 2642730
[TBL] [Abstract] [Full Text] [Related]
16. Cytoxan, epirubicin, methotrexate and 5-fluorouracil with hormonal synchronization (tamoxifen/premarin) in advanced breast cancer. Preliminary results.
Zaniboni A; Simoncini E; Marpicati P; Gorni F; Cervi GC; Marini G
Chemioterapia; 1986 Oct; 5(5):341-6. PubMed ID: 3024851
[TBL] [Abstract] [Full Text] [Related]
17. [Experience in rehabilitating cancer patients at sanatoria and health resorts].
Tsurkerman IM; Mikhno LE
Vopr Onkol; 1982; 28(7):77-9. PubMed ID: 7101834
[TBL] [Abstract] [Full Text] [Related]
18. Combination chemotherapy in advanced postmenopausal mammary carcinoma. A comparison between VAC and VACM therapy.
Mattsson W; Arwidi A; von Eyben F; Lindholm CE
Acta Radiol Oncol Radiat Phys Biol; 1979; 18(5):431-44. PubMed ID: 394576
[TBL] [Abstract] [Full Text] [Related]
